Atrial fibrillation after coronary artery bypass surgery: Predictors and the role of MgSO4 replacement

Journal of Cardiac Surgery

Volumn 11, Issue 6, 1996, Pages 421-427

  Nurözler, Feza ^a,b   Tokgözoglu, Lale ^a   Pasaoglu, Ilhan ^a   Böke, Erkmen ^a   Ersoy, Ünsal ^a   Bozer, A Yüksel ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAGNESIUM SULFATE; POTASSIUM; PROPRANOLOL;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PROPHYLAXIS; RISK FACTOR;

EID: 0030425158     PISSN: 08860440     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8191.1996.tb00076.x     Document Type: Article

References (42)

1. Caretta O, Mercanti CA, de Nardo D, et al: Ventricular conduction defects and atrial fibrillation after coronary artery bypass grafting. Multivariate analysis of preoperative, intraoperative and postoperative variables. Eur Heart J 1991;12: 1107-1111.
2. Crosby LH, Pifalo WB, Kathleen RW: Risk factors for atrial fibrillation after coronary artery bypass grafting. Am J Cardiol 1990;66:1520-1522.
3. Lamb RK, Prabhakar G, Smith S, et al: The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. Eur Heart J 1988;9:32-36.
4. Leitch JW, Thompson D, Braid DK, et al: The importance of age as a predictor of atrial fibrillation and flutter after CABG. J Thorac Cardiovasc Surg 1990;100:338-342.
5. Davidson A, Hartz R, Kaplan K, et al: Prophylaxis of supraventricular tachyarrhythmias after CABG with oral verapamil: A randomized double-blind trial. Ann Thorac Surg 1985;39:336-339.
6. Michelson EL, Morganfoth J, Mac Vough H: Postoperative arrhythmias after coronary artery and cardiac valvular surgery detected by long term electrocardiographic monitoring. Am Heart J 1979;97:442-448.
7. Ormerod OJM, McGregor CGA, Stone DC, et al: Arrhythmias after coronary bypass surgery. Br Heart J 1984;51:618-621.
8. Salem B, Chaudry A, Haikal M, et al: Sustained supraventricular tachyarrhythmias following CABG comparing mammary versus saphenous vein graft. Angiology 1991;42:441-446.
9. Rubin DA, Nieminski KE, Reed GE, et al: Predictors, prevention, and long term prognosis of atrial fibrillation after CABG operations. J Thorac Cardiovasc Surg 1985;94:331-335.
10. Parker BF, Hayes CG, Bove EL, et al: Supraventricular arrhythmias following coronary artery bypass. The effect of preoperative digitalis. J Thorac Cardiovasc Surg 1983;86:594-600.
11. Santoli E, Mattia PG, Scrofani R: Atrial fibrillation and flutter after open heart operations. Ann Thorac Surg 1992;53:940-941.
12. Rose MR, Glassman E, Spencer FC: Arrhythmias following cardiac surgery: Relation to serum digoxin levels. Am Heart J 1975;89:288-294.
13. Andrews CA, Sharon CR, Jesse AB, et al: Prevention of supraventricular arrhythmias after coronary bypass surgery: A meta-analysis of randomized control trials. Circulation 1991;84 (Suppl III):III-236-III-244.
14. Nystrom U, Edvardsson N, Berggren H, et al: Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypasss surgery. Thorac Cardiovasc Surg 1993;41:34-37.
15. Bozer AY, Iliçin G, Apikoglu A, et al: Serum electrolyte changes during extracorporeal circulation. Jpn Heart J 1972;13:195-200.
16. Fanning WJ, Thomas CS, Roach A, et al: Prophlaxis of atrial fibrillation with magnesium sulphate after CABG. J Thorac Cardiovasc Surg 1993;52:529-533.
17. Iliçin G, Apikogiu A, Bozer AY, et al: The effect of extracorporeal circulation on the magnesium metabolism. Hac Bul Med Surg 1971;4:103-113.
18. Khan RMA, Hodge JS, Basset HFM: Magnesium in open heart surgery. J Thorac Cardiovasc Surg 1973;66:188-191.
19. Scheinmen MM, Sullivan RW, Hatchinson JC, et al: Clinical significance of changes in serum magnesium on patients undergoing cardiopulmonary bypass. J Cardiovasc Surg 1971;61: 135-139.
20. Scheinman MM, Sullivan RW, Hyatt KN: Magnesium metabolism in patients undergoing cardiopulmonary bypass. Circulation 1989;39 (Suppl 1):235-241.
21. Aranki SF, Shaw PD, Adams DH, et al: Predictors of atrial fibrillation after coronary artery surgery - current trends and impact on hospital resources. Circulation 1996;94:380-397.
22. Dixon FE, Genton E, Vacek JL, et al: Factors predisposing to supraventricular tachyarrhythmias after coronary artery bypass grafting. Am J Cardiol 1986;58:476-478.
23. Creswell L, Schuessler RB, Rosenbloom M, et al: Hazards of postoperative atrial arrhythmias. Ann Thorac Surg 1993;56:539-549.
24. Fuller JA, Adams GG, Buxton B, et al: Atrial fibrillation after CABG. J Thorac Cardiovasc Surg 1989;97:821-825.
25. Leitch JW, Thompson D, Braid DK, et al: The importance of age as a predictor of atrial fibrillation and flutter after CABG. J Thorac Cardiovasc Surg 1990;100:338-342.
26. Kalman JM, Munawar M, Howes LG, et al: Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995;60:1709-1715.
27. Waldo AL: Mechanism of atrial fibrillation, atrial flutter and ectopic atrial tachycardia - A brief review. Circulation 1997;75(Suppl 3):37-40.
28. Kannel WB, Abbott RD, Savage DD, et al: Epidemiologic features of chronic atrial fibrillation: The Framingham study. N Engl J Med 1982;306:1018-1022.
29. Cameron A, Schwartz MJ, Kronmal RA, et al: Prevalence and significance of atrial fibrillation in coronary artery disease (CASS registry). Am J Cardiol 1988;61:714-717.
30. De Leeuw PW, Falke HE, Vandongan R, et al: Effects of beta-adrenergic blockade on diurnal variability of blood pressure and plasma noradrenalin levels. Acta Med Scand 1977;202:389-393.
31. Tchervenkov CI, Wynands JE, Symes JF, et al: Persistent atrial activity during cardioplegic arrest: A possible factor in the etiology of postoperative supraventricular tachyarrhythmias. Ann Thorac Surg 1983;36:437-443.
32. Mullen JC, Khan N, Weisel RD, et al: Atrial activity during cardioplegia and postoperative arrhythmias. J Thorac Cardiovasc Surg 1987;94: 558-565.
33. Cox JL: A perspective of postoperative atrial fibrillation in cardiac operations. Ann Thorac Surg 1993;56:405-409.
34. Louagie Y, Gonzalez M, Collard E, et al: Assessment of two venous drainage techniques in coronary artery bypass graft surgery. Thorac Cardiovasc Surg 1989;37:169-173.
35. Reinhart RA, Marx JJ, Broste SK, et al: Myocardial magnesium: Relation to laboratory and clinical variables in patients undergoing cardiac surgery. J Am Coll Cardiol 1991;17:651-656.
36. Crosby LH, Pifalo WB, Kathleen RW: Risk factors for atrial fibrillation after CABG. Am J Cardiol 1990;66:1520-1522.
37. Reinhart RA: Magnesium metabolism. Arch Intern Med 1988;148:2415-2420.
38. Iseri LT: Magnesium and cardiac arrhythmias. Magnesium 1986;5:11-126.
39. Zwerling HK: Does exogenous magnesium suppress myocardial irritability and tachyarrhythmias in the nondigitalized patients. Am Heart J 1987;113:1046-1053.
40. Seelig M: Cardiovascular consequences of magnesium deficiency and loss: Pathogenesis, prevalence and manifestations - Magnesium and chloride loss in refractory potassium depletion. Am J Cardiol 1989;63:4G-21G.
41. Di Carlo LA, Morady F, Krol RB, et al: Effects of magnesium sulphate on cardiac conduction and refractoriness in humans. J Am Coll Cardiol 1986;7:1356-1362.
42. Parikka H, Toivonen L, Pellinen T, et al: The influence of intravenous magnesium sulphate on the occurrence of atrial fibrillation after coronary artery bypass operation. Eur Heart J 1993;14: 251-258.